BackgroundCheck.run
Search For

Christine Lo, 463556 S State St UNIT 301, Chicago, IL 60609

Known as:
Christine Lo Mui Christine L Mui Mui Christine Lo Mui Yuk Kiang Lo Christine Lomui Cathy Lo Arthur Polland
Related to:
Yuk Kiang Mui 31

Christine Lo Phones & Addresses

Chicago, IL   

19308 Mansfield Ln, Mokena, IL 60448    708-4796622   

Get Report
Control this profile

Mentions for Christine Lo

Christine Lo resumes & CV records

Resumes

Christine Lo Photo 40

Senior Catering Manager At Waldorf Astoria Chicago

Position:
Senior Catering Manager at Waldorf Astoria Chicago
Location:
Greater Chicago Area
Industry:
Hospitality
Work:
Waldorf Astoria Chicago - Greater Chicago Area since Nov 2012
Senior Catering Manager Hard Rock Hotel Chicago Sep 2009 - Oct 2012
Catering Sales Manager Hard Rock Hotel Chicago Oct 2007 - Sep 2009
Group Sales Manager Hard Rock Hotel Chicago Nov 2006 - Oct 2007
Catering & Sales Coordinator
Education:
Michigan State University 2001 - 2005
BA, Hospitality Business
Skills:
Event Management, Hospitality, Hotels, Event Planning, Catering, Hospitality Management, Hospitality Industry, Food & Beverage, Marketing, Tourism
Christine Lo Photo 41

Executive Assistant

Location:
1 west Superior St, Chicago, IL 60654
Industry:
Management Consulting
Work:
Waldorf Astoria Chicago Nov 1, 2012 - Oct 2016
Senior Catering Manager Mckinsey & Company Nov 1, 2012 - Oct 2016
Executive Assistant Hard Rock Hotel Chicago Sep 2009 - Nov 2012
Catering Sales Manager Hard Rock Hotel Chicago Oct 2007 - Sep 2009
Group Sales Manager Hard Rock Hotel Chicago Nov 2006 - Oct 2007
Catering and Sales Coordinator
Education:
Michigan State University Dec 2005
Bachelors, Bachelor of Arts, Hospitality, Business Michigan State University 2005
Skills:
Catering, Hotels, Hospitality, Event Management, Event Planning, Meeting Planning, Food and Beverage, Hospitality Industry, Hospitality Management, Sales, Parties, Banquets, Marketing, Hotel Management, Tourism, Trade Shows, Restaurants, Corporate Events, Customer Service, Convention Services
Christine Lo Photo 42

Procurement Card Manager

Location:
Chicago, IL
Work:

Procurement Card Manager
Education:
Keller Graduate School of Management of Devry University
Christine Lo Photo 43

Pharmacist

Location:
Chicago, IL
Industry:
Hospital & Health Care
Work:
Onepoint Patient Care
Pharmacist Cvs Pharmacy Oct 2007 - May 2016
Pharmacist Intern Rush University Medical Center Sep 2014 - Nov 2014
Student Pharmacist Jewel-Osco Mar 2014 - May 2014
Pharmacy Intern Northwestern Memorial Hospital Nov 2013 - Mar 2014
Intern Pharmacist Meijer Pharmacy Sep 2013 - Nov 2013
Intern Pharmacist Cvs Health Sep 2013 - Nov 2013
Pharmacy Manager Uc Davis Medical Center Mar 2007 - Jun 2007
Intern
Education:
Roosevelt University 2013 - 2016
Doctorates, Doctor of Pharmacy, Pharmacy University of California, Davis 2004 - 2009
Bachelors, Psychology, Communications
Skills:
Pharmacy, Healthcare, Powerpoint, Medication Therapy Management, Cpr Certified, Pharmacists, Community Pharmacy, Patient Counseling, Pharmacy Automation, Pharmacy Practice, Immunization, Compounding, Clinical Pharmacy, Certified Immunizer, Pharmacy Benefit Management, Clinical Pharmacology, Pharmacy Technicians, Vaccinations
Christine Lo Photo 44

Christine Lo

Christine Lo Photo 45

Christine Lo

Christine Lo Photo 46

Christine Lo

Location:
United States
Christine Lo Photo 47

Graduate Student At University Of California At San Diego

Position:
Graduate Student at University of California at San Diego
Location:
San Diego, California
Industry:
Computer Software
Work:
University of California at San Diego since Sep 2009
Graduate Student Microsoft Jun 2008 - Aug 2008
Program Manager
Education:
University of California, San Diego 2009 - 2013
PhD, Computer Science Engineering University of California, Berkeley 2005 - 2009
BS, Electrical Engineering and Computer Sciences Texas Academy of Math and Science 2003 - 2005

Publications & IP owners

Us Patents

Methods And Systems For Dynamic Variant Thresholding In A Liquid Biopsy Assay

US Patent:
2022036, Nov 17, 2022
Filed:
Jul 6, 2022
Appl. No.:
17/858872
Inventors:
- Chicago IL, US
Wei Zhu - Naperville IL, US
Justin David Finkle - Chicago IL, US
Christine Lo - Chicago IL, US
Terri M. Driessen - Chicago IL, US
International Classification:
G16B 30/10
G16B 20/40
G16B 20/20
Abstract:
Methods, systems, and software are provided for validating a somatic sequence variant in a subject having a cancer condition. Sequence reads are obtained from sequencing cell-free DNA fragments in a liquid biopsy sample of the subject. Sequence reads are aligned to a reference sequence. A variant allele fragment count and locus fragment count are identified for a candidate variant that maps to a locus in the reference sequence. The variant allele fragment count is compared against a dynamic variant count threshold for the locus. The threshold is based on a pre-test odds of a positive variant call for the locus, based on the prevalence of variants in a genomic region including the locus in a cohort of subjects having the cancer condition. The somatic sequence variant in the subject is validated, or rejected, when the variant allele fragment count for the candidate variant satisfies, or does not satisfy, the threshold.

Molecular Response And Progression Detection From Circulating Cell Free Dna

US Patent:
2022036, Nov 17, 2022
Filed:
Jul 7, 2022
Appl. No.:
17/859599
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Jonathan Alexander Heiss - Chicago IL, US
Robert Tell - Chicago IL, US
Sun Hae Hong - Belmont CA, US
International Classification:
G16B 40/00
G16B 20/20
G16B 5/20
G06F 30/27
Abstract:
Methods, systems, and software are provided for monitoring a cancer condition of a test subject. The method includes obtaining a liquid biopsy sample from the subject at a second time point, occurring after a first time point, containing cell-free DNA fragments. Low-pass whole genome methylation sequencing of the cell-free DNA fragments is performed to obtain nucleic acid sequences having a methylation pattern for a corresponding cell-free DNA fragment. The nucleic acid sequences are mapped to a location on a reference genome. Methylation metrics are determined based on the methylation patterns and mapped locations of the nucleic acid sequences. A circulating tumor fraction is estimated from the methylation metrics, and the estimate is compared to an estimate of the circulating tumor fraction for the test subject at the first time point.

Estimation Of Circulating Tumor Fraction Using Off-Target Reads Of Targeted-Panel Sequencing

US Patent:
2022032, Oct 13, 2022
Filed:
Nov 16, 2021
Appl. No.:
17/527646
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Robert Tell - Chicago IL, US
Wei Zhu - Naperville IL, US
Terri M. Driessen - Chicago IL, US
International Classification:
G16B 30/20
G16B 20/10
Abstract:
Methods, systems, and software are provided for estimating a circulating tumor fraction for a test subject. Sequence reads are obtained from a panel-enriched sequencing reaction, including sequences for a first plurality of cfDNA fragments corresponding to probe sequences and a second plurality of cfDNA fragments not corresponding to probe sequences. Bin-level coverage ratios are determined from the sequences. Segments are formed by grouping adjacent bins based on similar coverage ratios and segment-level coverage ratios are determined based on bin-level coverage ratios for bins in the segment. For each simulated circulating tumor fraction in a plurality of circulating tumor fractions, segments are fitted to an integer copy state by identifying the integer copy state that best matches the segment-level coverage ratio. The circulating tumor fraction for the test subject is determined using error optimization between segment-level coverage ratios and integer copy states across the simulated circulated tumor fractions.

Molecular Response And Progression Detection From Circulating Cell Free Dna

US Patent:
2021039, Dec 23, 2021
Filed:
Jun 18, 2021
Appl. No.:
17/352231
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Jonathan Alexander Heiss - Chicago IL, US
Robert Tell - Chicago IL, US
Sun Hae Hong - Belmont CA, US
International Classification:
G16B 40/00
G16B 20/20
G16B 5/20
G06F 30/27
Abstract:
Methods, systems, and software are provided for monitoring a cancer condition of a test subject. The method includes obtaining a liquid biopsy sample from the subject at a second time point, occurring after a first time point, containing cell-free DNA fragments. Low-pass whole genome methylation sequencing of the cell-free DNA fragments is performed to obtain nucleic acid sequences having a methylation pattern for a corresponding cell-free DNA fragment. The nucleic acid sequences are mapped to a location on a reference genome. Methylation metrics are determined based on the methylation patterns and mapped locations of the nucleic acid sequences. A circulating tumor fraction is estimated from the methylation metrics, and the estimate is compared to an estimate of the circulating tumor fraction for the test subject at the first time point.

Methods And Systems For Dynamic Variant Thresholding In A Liquid Biopsy Assay

US Patent:
2021034, Nov 4, 2021
Filed:
Feb 18, 2021
Appl. No.:
17/179086
Inventors:
- Chicago IL, US
Wei Zhu - Naperville IL, US
Justin David Finkle - Chicago IL, US
Christine Lo - Chicago IL, US
Terri M. Driessen - Chicago IL, US
International Classification:
G16B 30/10
G16B 20/20
G16B 20/40
Abstract:
Methods, systems, and software are provided for validating a somatic sequence variant in a subject having a cancer condition. Sequence reads are obtained from sequencing cell-free DNA fragments in a liquid biopsy sample of the subject. Sequence reads are aligned to a reference sequence. A variant allele fragment count and locus fragment count are identified for a candidate variant that maps to a locus in the reference sequence. The variant allele fragment count is compared against a dynamic variant count threshold for the locus. The threshold is based on a pre-test odds of a positive variant call for the locus, based on the prevalence of variants in a genomic region including the locus in a cohort of subjects having the cancer condition. The somatic sequence variant in the subject is validated, or rejected, when the variant allele fragment count for the candidate variant satisfies, or does not satisfy, the threshold.

Estimation Of Circulating Tumor Fraction Using Off-Target Reads Of Targeted-Panel Sequencing

US Patent:
2021025, Aug 19, 2021
Filed:
Feb 18, 2021
Appl. No.:
17/179267
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Robert Tell - Chicago IL, US
Wei Zhu - Naperville IL, US
Terri M. Driessen - Chicago IL, US
International Classification:
G16B 30/20
G16B 20/10
Abstract:
Methods, systems, and software are provided for estimating a circulating tumor fraction for a test subject. Sequence reads are obtained from a panel-enriched sequencing reaction, including sequences for a first plurality of cfDNA fragments corresponding to probe sequences and a second plurality of cfDNA fragments not corresponding to probe sequences. Bin-level coverage ratios are determined from the sequences. Segments are formed by grouping adjacent bins based on similar coverage ratios and segment-level coverage ratios are determined based on bin-level coverage ratios for bins in the segment. For each simulated circulating tumor fraction in a plurality of circulating tumor fractions, segments are fitted to an integer copy state by identifying the integer copy state that best matches the segment-level coverage ratio. The circulating tumor fraction for the test subject is determined using error optimization between segment-level coverage ratios and integer copy states across the simulated circulated tumor fractions.

Possible Relatives

David Y Lo  Aaron C Lo  Denise A Lo  Danny S Lo  Derrick Lo  Diane Lo  Donald H Lo  Christine A Johnson  Christine M Stamps  Christine Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.